Article info

Download PDFPDF

Targeting IL-6 in COVID-19. Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and Sharma

Authors

  • Pier Leopoldo Capecchi Department of Medical Sciences, Surgery and Neurosciences, Section of Internal Medicine, COVID-19 Unit, Siena University Hospital, Siena, Toscana, Italy PubMed articlesGoogle scholar articles
  • Pietro Enea Lazzerini Department of Medical Sciences, Surgery and Neurosciences, Section of Internal Medicine, COVID-19 Unit, Siena University Hospital, Siena, Toscana, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Pier Leopoldo Capecchi, Department of Medical Sciences Surgery and Neurosciences. Section of Internal Medicine. COVID-19 Unit, Siena University Hospital, Siena 53100, Italy; capecchipl{at}unisi.it
View Full Text

Citation

Capecchi PL, Lazzerini PE
Targeting IL-6 in COVID-19. Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and Sharma

Publication history

  • Received July 21, 2020
  • Accepted July 22, 2020
  • First published July 31, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.